Patient Guide: Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 11 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07044687
Status: 🟢 Enrolling Now
Condition: Acute Myeloid Leukemia
Phase: PHASE4

Find a Study Location Near You

This study is available at 11 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Gurgaon, Haryana
  • • Bengaluru, Karnataka
  • • Thiruvananthapuram, Kerala
  • • And 8 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India - Join Clinical Trial NCTNCT07044687

How to Join This Clinical Trial - NCTNCT07044687

Learn how to participate in this PHASE4 trial studying an investigational therapy for Acute Myeloid Leukemia. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Acute Myeloid Leukemia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Acute Myeloid Leukemia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07044687 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 11 locations. Find a study site near you:

Clinical Research Site

Gurgaon, Haryana 122002 - India

Status: RECRUITING

Clinical Research Site

Bengaluru, Karnataka 560099 - India

Status: RECRUITING

Clinical Research Site

Thiruvananthapuram, Kerala 695011 - India

Status: RECRUITING

Clinical Research Site

Pune, Maharashtra 411004 - India

Status: RECRUITING

Clinical Research Site

Pune, Maharashtra 411004 - India

Status: RECRUITING

Clinical Research Site

New Delhi, National Capital Territory of Delhi 110029 - India

Status: RECRUITING

Clinical Research Site

New Delhi, National Capital Territory of Delhi 110085 - India

Status: RECRUITING

Clinical Research Site

Bhubaneswar, Odisha 751019 - India

Status: RECRUITING

Clinical Research Site

Chennai, Tamil Nadu 600035 - India

Status: RECRUITING

Clinical Research Site

Chennai, Tamil Nadu 600036 - India

Status: RECRUITING

And 1 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Acute Myeloid Leukemia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation